Open for bids Tender Germany ICB TOT Ref. 152587815

Conclusion of a Non-Exclusive Discount Agreement Tender - 152587815

Tender notice from Germany, published on 17 Nov 2026.

Executive Summary

Title/Summary: Tender for a non-exclusive discount agreement for the active ingredient Pamidronate (ATC M05BA03) issued by DAK-Gesundheit in Hamburg, Germany, valid from January 1, 2027, to December 31, 2028, with an option to extend for an additional 12 months.

Scope Of Work: The DAK-Gesundheit intends to establish a framework discount agreement under § 130a Abs. 8 SGB V for the active ingredient Pamidronate (ATC M05BA03). This agreement will allow pharmaceutical companies to enter into discount contracts for medications covered by statutory health insurance. The contracts will commence on January 1, 2027, and conclude on December 31, 2028, with a possibility of a 12-month extension. Interested bidders must submit proposals detailing the medications they wish to include, with specific documentation required by the DAK-Gesundheit.

Qualification Criterion: To qualify, bidders must submit the following documents by email to DAK-Gesundheit: a proposal letter, acknowledgment of contractual terms including the specified discounts, and completed annexes detailing the medications. These documents must be sent in electronic format, specifically as an Excel file for Annex 2. Submissions must be received by the 5th of the month preceding the desired contract start date. Late submissions may still allow for future participation at designated times.

Key facts

Summary
Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pamidronic Acid, Atc M05ba03 for the Period January 1St, 2027 - December 31St, 2028 (Plus V. Option 1X12 Months)
TOT Ref. No.
152587815
Document Ref. No.
Login to see
Country
Germany
Notice type
Tender
Competition
ICB
Publication date
17 Nov 2026
Bid deadline
05 Nov 2029
EMD
Refer Document
Tender value
EUR 1.00
Purchaser ownership
Public
Financier
Self Financed

CPV classification

Purchaser details

Purchaser contact is for registered users

Login to see details

Tender details

Tender details are for registered users

Login to see details

Documents

Tender Notice
Login to view

Similar tenders

Germany Public Procurement Intelligence

Frequently asked questions

The last date to submit a bid for Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Pamidronic Acid, Atc M05ba03 for the Period January 1St, 2027 - December 31St, 2028 (Plus V. Option 1X12 Months) is 05 Nov 2029. Submit before this date to be considered.

This tender has been issued by DAK HEALTH in Germany.

The estimated tender value is EUR 1.00. EMD / bid security details are provided in the tender document.

This tender is Self Financed

The tender is classified under the following CPV code(s): 33600000 - Pharmaceutical products.

The tender notice and related documents are listed in the Documents section above. Select a document to view or download it. Please log in or register to access the documents. If you cannot find additional documents in the Documents section, please log in to your account and Send Document Request from your account section.

The TendersOnTime reference is 152587815. The purchaser document reference is available after login.

See the Similar Tenders section on this page or browse other tenders from Germany.

This tender falls under Materials and Products, Technology and Equipment in Germany. Suppliers in these sectors can track similar Germany tenders using CPV-based alerts.